Mitoxantrone for childhood cancer more cardiotoxic than thought

In pediatric cancer patients, mitoxantrone appears to be at least ten times as cardiotoxic as doxorubicin therapy, while daunorubicin therapy may be less so, according to a large cohort study.

Read more: https://www.mdlinx.com/pediatrics/top-medical-news/article/2019/02/12/7557106